查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933821

自动化血库分析仪市场按技术、分析仪类型、吞吐量、工作流程、操作模式、最终用户和应用划分－全球预测，2026-2032年

Automated Blood Bank Analyzers Market by Technology, Analyzer Type, Throughput, Workflow, Mode Of Operation, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，自动化血库分析仪市值为9.3857亿美元，预计2026年将成长至10.0933亿美元，年复合成长率为8.43%，到2032年将达到16.5432亿美元。

关键市场统计数据
基准年 2025 9.3857亿美元
预计年份：2026年 10.933亿美元
预测年份 2032 16.5432亿美元
复合年增长率 (%) 8.43%

本文概述了自动化和整合诊断如何改变血库的工作流程、安全优先事项和采购决策标准。

自动化血库分析仪已从实验室的特定工具转变为临床输血服务、捐血筛检计画和研究工作流程中的核心资产。感测器技术、试剂化学和软体驱动自动化技术的进步，共同提升了人们对分析仪的通量、准确性和可追溯性的期望，促使人们重新思考严重依赖人工操作的传统流程。随着医疗机构将病患安全和营运韧性置于优先地位，整合了相容性测试、成分处理监控和捐血筛检功能的分析仪正日益被视为战略投资，而不仅仅是资本设备。

深入探讨正在重新定义分析设备能力、采购模式和检查室优先事项的技术、监管和营运变革。

由于技术、监管和营运等因素的共同作用，血库分析仪市场正经历变革性的转变。首先，流式细胞技术、光强度检测和先进离心技术的成熟，正推动製造商在小型化和多重检测方面进行创新，从而在紧凑的面积内实现更可靠的兼容性测试和更快速的捐血筛检。同时，支援决策规则、审核追踪和远距离诊断的软体平台，正在实现预测性维护并减少停机时间。这正促使采购模式从简单的资本支出转向以绩效为基础的服务合约。

对2025年美国关税调整对检查室采购商的筹资策略、供应链韧性和供应商商业模式的影响进行全面分析

2025年美国关税和贸易政策的变化为医疗设备买家和製造商的筹资策略和供应链规划带来了新的复杂性。仪器、配件和试剂的进口关税和分类变更导致到岸成本波动，迫使采购团队重新评估供应商选择标准、合约条款和库存缓衝策略。为此，许多供应商和检查室网路正在加快供应商多元化步伐，包括扩大製造地和开发替代采购管道，以降低单一来源风险。

一个详细的细分框架，将技术模式、分析仪配置、最终用户需求和操作流程相匹配，以指导采购和部署决策。

了解每种产品和服务细分领域的细微差别对于设计满足临床需求和营运限制的实施策略至关重要。从技术角度来看，分析仪器的评估主要依据离心、流式细胞技术和光强度。在离心方面，固定角转子和摆动式转子配置会影响分离效率和微孔板相容性；流式细胞技术产品的评估则取决于其单色和多色检测能力，这会影响检测的多重性和复杂性。光强度平台则根据光强度和检测法法进行区分，这会影响可检测的分析物范围和可自动化的检测类型。

区域分析重点阐述了美洲、欧洲、中东和非洲以及亚太地区在监管、采购和基础设施环境方面的差异将如何影响采用和供应商策略。

区域趋势对全球范围内的采用曲线、监管预期和商业模式有显着影响。美洲地区由于拥有大规模的医院网络、集中化的血液服务以及成熟的法规环境（强调可追溯性和品管系统），因此需求强劲。在该地区，买家偏好具有整合IT连接和服务框架的全自动化系统，以支援多站点营运。由于停机会带来重大的临床和声誉风险，因此拥有区域内物流和本地服务能力的供应商在长期伙伴关係中往往更具优势。

竞争格局分析：产品差异化、卓越的售后服务和供应链策略决定供应商的成功和长期伙伴关係。

自动化血库分析仪领域的竞争动态由几个共同的策略主题所塑造：透过整合软体和封闭式工作流程实现产品差异化；在服务和试剂协议方面进行商业性创新；以及提供最大限度减少停机时间的营运支援能力。领先的製造商强调平台可靠性、强大的验证方案以及与实验室资讯系统的无缝互通性，以满足临床客户不断变化的文件需求。同时，能够展现出色的售后服务、快速的备件物流以及透过远距离诊断进行预防性维护的供应商，往往能够赢得更长期的伙伴关係关係和更高的客户满意度。

为製造商和经销商提供切实可行的策略性倡议，以整合产品创新、服务品质和灵活的商业模式，从而降低购买门槛并加速产品普及。

产业领导者应积极整合产品创新、供应链韧性和以客户为中心的商业模式，以创造价值并降低采用门槛。首先，投资于可互通的软体架构，以实现与实验室资讯系统的无缝集成，并支援用于品质保证的高级分析。此类投资透过实现快速决策支援和审核，降低了采用门槛并提升了自动化的感知价值。其次，优先考虑模组化仪器设计，以实现逐步升级和灵活的试剂规格。这可以保护采购机构免受快速过时的影响，并允许进行增量资本投资。

采用稳健的混合方法研究，结合实务工作者访谈、技术检验审查和情境分析，为采购和实施提供实际的见解。

本执行摘要依据的研究整合了定性和定量数据，旨在全面了解市场及其对营运的影响。主要研究包括对来自不同医疗机构的实验室主任、采购负责人、临床病理学家和技术服务经理进行结构化访谈，以获取有关实施挑战、临床需求和维护实践的第一手资料。这些实践者的见解与技术文件、监管指南和供应商产品规格进行交叉验证，以确保对功能和限制的解读平衡且检验。

一份简明扼要的综述，重点阐述了互通性、服务弹性以及客製化采购方法对于优化血库营运和安全的战略重要性。

总之，自动化血库分析仪已成为现代输血服务、捐血筛检计画和实验室的核心组成部分。先进检测技术、软体驱动的工作流程整合以及不断发展的商业模式的融合，正促使买家对系统的期望从分析精度转向提供营运弹性和显着的整体流程效益。 2025 年贸易政策的演变凸显了供应链敏捷性和合约创新性的重要性，鼓励相关人员实现筹资策略多元化，并探索与绩效挂钩的采购合约。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按技术分類的自动化血库分析仪市场

  • 离心
    • 固定角转子
    • 摆动式铲斗转子
  • 流式细胞技术
    • 多色的
    • 单色
  • 光度学
    • 光强度
    • 浊度测量

9. 按分析仪类型分類的自动化血库分析仪市场

  • 全自动
  • 模组化的
  • 半自动

第十章：依处理能力分類的自动化血库分析仪市场

  • 高的
  • 低的
  • 中等的

第十一章：依工作流程分類的自动化血库分析仪市场

  • 封闭式系统
  • 开放系统

第十二章 按操作模式分類的自动化血库分析仪市场

  • 批量方法
  • 连续方法

第十三章 依最终用户分類的自动化血库分析仪市场

  • 诊断检查室
  • 医院血库
    • 社区医院
    • 三级医院
  • 研究所

第十四章 自动化血库分析仪市场（依应用领域划分）

  • 一致性测试
  • 原料加工
  • 捐血筛检

第十五章 各地区自动化血库分析仪市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 自动化血库分析仪市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国自动化血库分析仪市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国自动化血库分析仪市场

第十九章 中国自动化血库分析仪市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • BAG Healthcare GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi
  • Fujirebio
  • Grifols, SA
  • Haemonetics Corporation
  • Hologic, Inc.
  • Immucor, Inc.
  • Macopharma
  • MAK-System
  • NIPRO Corporation
  • Ortho Clinical Diagnostics, Inc.
  • Polymed Medical Devices
  • Quotient Limited
  • Sarstedt AG & Co. KG
  • Sartorius AG
  • Shenzhen Mindray Biomedical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-C36616F69962

The Automated Blood Bank Analyzers Market was valued at USD 938.57 million in 2025 and is projected to grow to USD 1,009.33 million in 2026, with a CAGR of 8.43%, reaching USD 1,654.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 938.57 million
Estimated Year [2026] USD 1,009.33 million
Forecast Year [2032] USD 1,654.32 million
CAGR (%) 8.43%

Contextual overview of how automation and integrated diagnostics are reshaping blood bank workflows, safety priorities, and procurement decision criteria

Automated blood bank analyzers have transitioned from niche laboratory tools into central assets for clinical transfusion services, donor screening programs, and research workflows. Advances in sensor technology, reagent chemistry, and software-driven automation have collectively raised expectations around throughput, accuracy, and traceability, prompting laboratories to rethink legacy processes that relied heavily on manual intervention. As institutions prioritize patient safety and operational resilience, analyzers that integrate compatibility testing, component processing oversight, and donor screening capabilities are increasingly viewed as strategic investments rather than mere capital equipment.

Over the past several years, manufacturers have concentrated on reducing hands-on time while enhancing assay reliability and regulatory compliance. Interoperability with laboratory information systems, barcode-driven sample tracking, and closed-system workflow options now form the baseline requirements for procurement committees. Consequently, laboratory directors are reevaluating analyzer selection not only in terms of analytical performance but also total cost of ownership, staff training needs, and the capacity to adapt to evolving clinical guidelines. This introduction outlines the context for deeper exploration in the subsequent sections, where technological shifts, policy impacts, segmentation nuances, regional dynamics, and recommended actions converge to inform strategic decisions.

Detailed exploration of technological, regulatory, and operational transformations that are redefining analyzer capabilities, procurement models, and laboratory priorities

The landscape for blood bank analyzers is undergoing transformative shifts driven by converging technological, regulatory, and operational forces. First, the maturation of flow cytometry, photometric detection, and refined centrifugation mechanics has pushed manufacturers to innovate around miniaturization and multiplexing, enabling more robust compatibility testing and faster donor screening within compact footprints. In parallel, software platforms that support decision rules, audit trails, and remote diagnostics are enabling predictive maintenance and reducing downtime, which in turn alters procurement models away from simple capital purchases toward performance-based service arrangements.

Second, the increasing emphasis on patient safety and standardization has raised the bar for validation procedures and traceability. Laboratories now expect analyzers to provide end-to-end documentation, from specimen accessioning to final result verification, which has encouraged the adoption of closed-system workflows where contamination risks and manual error are minimized. Third, supply chain resilience and reagent lifecycle management have become differentiators; vendors offering robust reagent availability, multi-site inventory visibility, and modular architectures that allow phased upgrades are gaining buyer interest. As a result, hospital networks and centralized diagnostic laboratories are examining total process impacts, including staff competencies, space requirements, and cross-functional integration, and are increasingly prioritizing solutions that offer scalability and seamless integration with broader laboratory ecosystems.

Finally, ongoing collaboration between clinical stakeholders and manufacturers is producing tailored instrument configurations and service models that meet specific institutional needs. These collaborative design efforts are enabling more rapid adoption cycles and are reinforcing the role of analyzers as strategic enablers of clinical and operational excellence rather than solely as analytical instruments.

Comprehensive analysis of how 2025 United States tariff adjustments are influencing procurement strategies, supply chain resilience, and vendor commercial models for laboratory buyers

Tariffs and trade policy shifts in the United States for 2025 have introduced new layers of complexity to procurement strategies and supply chain planning for medical device buyers and manufacturers alike. When import duties and classification changes alter landed costs for instrumentation, accessories, and reagents, procurement teams must reassess vendor selection criteria, contract terms, and inventory buffering strategies. In response, many suppliers and laboratory networks have accelerated their supplier diversification efforts, expanding manufacturing footprints and sourcing alternatives to mitigate exposure to single-origin risks.

Concurrently, higher import costs have amplified the appeal of modular and service-centric models that allow laboratories to phase investments while securing reagent and parts supply under long-term agreements. This transition has inspired creative commercial structures such as reagent-as-a-service arrangements, extended warranty bundles linked to uptime guarantees, and multi-year reagent procurement contracts designed to lock in pricing stability. Trade policy changes have also prompted intensified negotiations around transfer pricing, local assembly options, and the possibility of regional warehousing to minimize tariff impacts.

Importantly, these adjustments have not occurred in isolation. Laboratories are balancing tariff-induced cost pressures with demands for compliance, traceability, and clinical performance. As a result, strategic procurement now often includes scenario planning for regulatory and trade contingencies, collaboration with legal and supply chain teams, and greater reliance on data-driven risk assessments that weigh operational continuity against short-term cost fluctuations. The net effect is a marketplace where agility, geographic footprint, and contractual creativity are as influential as device performance in shaping long-term purchasing decisions.

In-depth segmentation framework that aligns technology modalities, analyzer configurations, end-user requirements, and operational workflows to guide procurement and deployment decisions

A nuanced understanding of product and service segments is essential for designing deployment strategies that align with clinical demands and operational constraints. Based on technology, analyzers are evaluated across centrifugation, flow cytometry, and photometry; within centrifugation, fixed angle rotor and swing bucket rotor configurations are examined for their differential impacts on separation efficiency and plate compatibility, while flow cytometry offerings are assessed by single color and multi color capability that dictates assay multiplexing and complexity. Photometry platforms are distinguished by spectrophotometry and turbidimetry modalities, which influence the range of detectable analytes and the types of assays that can be automated.

Based on analyzer type, considerations span fully automated systems that prioritize throughput and end-to-end workflow control, modular architectures that enable incremental expansion and customization, and semi automated instruments that balance manual steps with mechanized processes for smaller facilities. Based on end user, the market is contextualized across diagnostic laboratories, hospital blood banks, and research institutes; within hospital blood banks, distinctions between community hospitals and tertiary hospitals reveal divergent needs in scale, redundancy, and integration complexity. Based on application, clinical use cases include compatibility testing, component processing, and donor screening, each requiring specific assay support, traceability features, and workflow integration.

Throughput considerations categorize instruments into high, medium, and low throughput profiles, guiding decisions on staffing, shift patterns, and space planning. Workflow design considerations pit closed systems against open systems, with closed systems offering reduced contamination risk and standardized procedures, and open systems providing greater flexibility for bespoke assays. Finally, mode of operation-batch versus continuous-affects sample handling philosophies, reagent consumption patterns, and peak capacity planning. Taken together, these segmentation lenses provide a comprehensive framework to match analyzer capabilities to institutional requirements and to prioritize feature trade-offs during vendor evaluations.

Regional analysis highlighting how divergent regulatory, procurement, and infrastructure conditions across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and vendor strategy

Regional dynamics significantly influence adoption curves, regulatory expectations, and commercial models across the global landscape. The Americas exhibit strong demand driven by large hospital networks, centralized blood services, and a mature regulatory environment that emphasizes traceability and quality management systems. In this region, buyer preference often tilts toward fully automated systems with integrated IT connectivity and service frameworks that support multi-site operations. Suppliers that maintain regional logistics and localized service capabilities tend to perform better in long-term partnerships here, as downtime carries significant clinical and reputational risks.

Europe, Middle East & Africa present a heterogeneous set of conditions where regulatory regimes, procurement structures, and healthcare infrastructure vary widely. Western European markets often demand rigorous compliance documentation and compatibility with established laboratory information systems, while emerging markets within the region may prioritize cost-effective modular solutions and flexible reagent sourcing. In several Middle Eastern and African settings, the emphasis on capacity building and training creates opportunities for vendors offering comprehensive onboarding and localized technical support.

Asia-Pacific is characterized by rapid adoption in urban tertiary hospitals and growing investments in donor screening and regional blood services. Diverse regulatory landscapes and differing reimbursement frameworks influence how vendors structure their commercial terms, with many favoring local partnerships, regional assembly, or in-country service hubs to optimize responsiveness. Across all regions, cross-border supply chain strategies and the ability to offer tailored service agreements remain decisive factors in winning long-term contracts and scaling deployments.

Competitive landscape analysis showing how product differentiation, post-sales service excellence, and supply chain strategies determine vendor success and long-term partnerships

Competitive dynamics in the automated blood bank analyzer space are shaped by a few consistent strategic themes: product differentiation through integrated software and closed workflows, commercial innovation in service and reagent agreements, and operational support capabilities that minimize downtime. Leading manufacturers emphasize platform reliability, robust validation packages, and seamless interoperability with laboratory information systems to meet the evolving documentation demands of clinical customers. In turn, providers that can demonstrate strong post-sales performance, rapid spare-parts logistics, and proactive maintenance via remote diagnostics tend to secure longer-term partnerships and higher customer satisfaction scores.

Strategic partnerships and co-development agreements with clinical laboratories and research institutions are increasingly common as vendors seek to validate new assays and accelerate regulatory clearance pathways. Companies that offer modular product lines that can be upgraded in the field provide an attractive risk-mitigation pathway for buyers who need to phase capital expenditures. Additionally, firms that invest in training programs, certification of local service engineers, and transparent performance metrics differentiate themselves in procurement competitions where uptime and staff competence are paramount.

Finally, corporate strategies that prioritize supply chain diversification, regional warehousing, and reagent continuity programs resonate strongly with large hospital networks and national blood services. These operational commitments, combined with flexible commercial terms such as reagent-supply contracts and outcome-linked service levels, are proving decisive in securing multi-year engagements and fostering customer loyalty.

Actionable strategic initiatives for manufacturers and distributors that align product innovation, service excellence, and flexible commercial models to reduce buyer friction and accelerate adoption

Industry leaders should pursue a proactive blend of product innovation, supply chain resilience, and customer-centric commercial models to capture value and reduce adoption friction. First, invest in interoperable software architectures that enable seamless integration with laboratory information systems and support advanced analytics for quality assurance. Such investments lower implementation barriers and increase the perceived value of automation by enabling faster decision support and auditability. Second, prioritize modular instrument designs that allow incremental upgrades and flexible reagent formats, thereby protecting purchasing organizations against rapid obsolescence and enabling phased capital deployment.

Third, strengthen regional logistics and service networks to reduce downtime risk and reassure large-scale buyers. Establishing regional spare-parts depots, certifying local service teams, and deploying remote diagnostics capabilities will materially improve uptime performance and client retention. Fourth, craft commercially creative offerings such as reagent-as-a-service, outcome-based uptime guarantees, and training-embedded contracts that align vendor incentives with customer outcomes and create predictable revenue streams. Fifth, collaborate early with clinical stakeholders and regulatory bodies to co-develop validation protocols that expedite adoption while maintaining compliance.

Taken together, these recommendations will help manufacturers and distributors to align product roadmaps with real-world operational needs, reduce procurement hesitancy among buyers, and create scalable, resilient business models that withstand trade policy and supply chain fluctuations.

Robust mixed-methods research design combining practitioner interviews, technical validation reviews, and scenario analysis to produce actionable insights for procurement and implementation

The research underpinning this executive summary synthesizes qualitative and quantitative sources to produce an integrated view of the market and its operational implications. Primary research included structured interviews with laboratory directors, procurement officers, clinical pathologists, and technical service managers across diversified healthcare settings to capture firsthand accounts of deployment challenges, clinical requirements, and maintenance realities. These practitioner insights were triangulated with technical documentation, regulatory guidance, and vendor product specifications to ensure a balanced and verifiable interpretation of capabilities and constraints.

Secondary analysis incorporated peer-reviewed literature on assay performance, device validation studies, and policy documents that inform accreditation and compliance expectations. In addition, service contract templates, product manuals, and platform interoperability certifications were reviewed to assess vendor commitments around uptime, training, and reagent continuity. The research team applied scenario analysis to explore the operational impact of trade policy changes, considering variations in procurement strategies, supply chain configurations, and commercial terms.

To preserve analytical rigor, findings were cross-validated across multiple interviewees and documentary sources, and areas of significant divergence were highlighted for further investigation. Throughout the methodology, care was taken to avoid speculative market sizing and instead focus on actionable intelligence that directly informs procurement decisions, vendor comparisons, and implementation planning.

Concise synthesis emphasizing the strategic importance of interoperability, service resilience, and tailored procurement approaches to optimize blood bank operations and safety

In conclusion, automated blood bank analyzers now represent pivotal components of modern transfusion services, donor screening programs, and research laboratories. The confluence of advanced detection technologies, software-driven workflow integration, and evolving commercial models has shifted buyer expectations toward systems that deliver not only analytical accuracy but also operational resilience and clear total process benefits. Trade policy developments in 2025 have underscored the importance of supply chain agility and contractual creativity, prompting stakeholders to diversify sourcing strategies and explore performance-linked procurement arrangements.

Segmentation analysis reinforces the need for tailored solutions: technology modality, analyzer type, end-user profile, application, throughput, workflow configuration, and mode of operation each exert distinct influences on instrument selection and implementation success. Regional nuances further shape procurement priorities, with buyers in the Americas, Europe Middle East & Africa, and Asia-Pacific responding to differing regulatory frameworks, infrastructure maturity, and service expectations. Ultimately, vendors that combine interoperable platforms, modular upgrade paths, strong regional support, and innovative commercial terms will be best positioned to meet the complex needs of modern blood bank operations.

Decision-makers should therefore approach acquisitions with a holistic lens that balances clinical performance with service continuity, staff competencies, and long-term adaptability, ensuring that investments contribute to safer, more efficient, and more resilient transfusion ecosystems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Blood Bank Analyzers Market, by Technology

  • 8.1. Centrifugation
    • 8.1.1. Fixed Angle Rotor
    • 8.1.2. Swing Bucket Rotor
  • 8.2. Flow Cytometry
    • 8.2.1. Multi Color
    • 8.2.2. Single Color
  • 8.3. Photometry
    • 8.3.1. Spectrophotometry
    • 8.3.2. Turbidimetry

9. Automated Blood Bank Analyzers Market, by Analyzer Type

  • 9.1. Fully Automated
  • 9.2. Modular
  • 9.3. Semi Automated

10. Automated Blood Bank Analyzers Market, by Throughput

  • 10.1. High
  • 10.2. Low
  • 10.3. Medium

11. Automated Blood Bank Analyzers Market, by Workflow

  • 11.1. Closed System
  • 11.2. Open System

12. Automated Blood Bank Analyzers Market, by Mode Of Operation

  • 12.1. Batch
  • 12.2. Continuous

13. Automated Blood Bank Analyzers Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Hospital Blood Banks
    • 13.2.1. Community Hospitals
    • 13.2.2. Tertiary Hospitals
  • 13.3. Research Institutes

14. Automated Blood Bank Analyzers Market, by Application

  • 14.1. Compatibility Testing
  • 14.2. Component Processing
  • 14.3. Donor Screening

15. Automated Blood Bank Analyzers Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Automated Blood Bank Analyzers Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Automated Blood Bank Analyzers Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Automated Blood Bank Analyzers Market

19. China Automated Blood Bank Analyzers Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abbott Laboratories
  • 20.6. BAG Healthcare GmbH
  • 20.7. Beckman Coulter, Inc.
  • 20.8. Becton, Dickinson and Company
  • 20.9. Bio-Rad Laboratories, Inc.
  • 20.10. DiaSorin S.p.A.
  • 20.11. F. Hoffmann-La Roche Ltd
  • 20.12. Fresenius Kabi
  • 20.13. Fujirebio
  • 20.14. Grifols, S.A.
  • 20.15. Haemonetics Corporation
  • 20.16. Hologic, Inc.
  • 20.17. Immucor, Inc.
  • 20.18. Macopharma
  • 20.19. MAK-System
  • 20.20. NIPRO Corporation
  • 20.21. Ortho Clinical Diagnostics, Inc.
  • 20.22. Polymed Medical Devices
  • 20.23. Quotient Limited
  • 20.24. Sarstedt AG & Co. KG
  • 20.25. Sartorius AG
  • 20.26. Shenzhen Mindray Biomedical Electronics Co., Ltd.
  • 20.27. Siemens Healthineers AG
  • 20.28. Terumo BCT, Inc.
  • 20.29. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIXED ANGLE ROTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIXED ANGLE ROTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIXED ANGLE ROTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SWING BUCKET ROTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SWING BUCKET ROTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SWING BUCKET ROTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MULTI COLOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MULTI COLOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MULTI COLOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SINGLE COLOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SINGLE COLOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SINGLE COLOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SPECTROPHOTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SPECTROPHOTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SPECTROPHOTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TURBIDIMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TURBIDIMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TURBIDIMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HIGH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HIGH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HIGH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY LOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY LOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY LOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MEDIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MEDIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TERTIARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TERTIARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPATIBILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPATIBILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPATIBILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DONOR SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DONOR SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DONOR SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 207. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 211. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 212. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 247. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 248. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 249. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 259. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 260. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 261. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PHOTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITAL BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)